Drug overdose deaths in the United States fell by approximately 14% in 2025 compared with 2024, according to data from the Centers for Disease Control and Prevention. The 69,973 fatal overdoses recorded nationwide in 2025 marked the lowest annual toll since at least 2019 and represented a decline of roughly 11,300 deaths from the prior year.

The decrease extends a trend that began in mid-2023, when overdose deaths peaked at 112,418 in a 12-month period. Public health officials attributed the sustained decline to structural interventions, including wider use of medications that reduce opioid cravings and reverse overdoses. “This is very good news,” said Dr. Nora Volkow, head of the U.S. National Institute on Drug Abuse.

Several states reported substantial improvements. Alabama, New York, and Virginia each recorded 25% to 30% fewer overdose deaths in the 12 months ending December 2025. In New York, opioid deaths from black-market fentanyl, heroin, and pain pills have been cut in half since 2022. “I am very pleased that over the past three years, we have seen a decline,” said New York Governor Kathy Hochul.

Experts pointed to expanded access to naloxone, the opioid overdose reversal drug, as a key factor. “Access to naloxone or Narcan has become widespread in communities. We're beginning to see that naloxone is first aid and that is absolutely critical,” said Beth Meyerson, a drug policy researcher who heads the Harm Reduction Research Lab at the University of Arizona's College of Medicine in Tucson.

Despite the progress, disparities persist. Overdose deaths remain high among older Americans and in many predominantly Black and Native American communities. Arizona, New Mexico, and North Dakota saw sharp increases in fatal overdoses in 2025. Meyerson noted that “Arizona is the gateway for fentanyl into the United States [from Mexico].” She also said, “Two studies by our team documented the drive time in Arizona is over two hours for opioid treatment in rural communities.”

Volkow emphasized ongoing challenges, particularly in the Southwest. “Widespread use of potent methamphetamines in Arizona and New Mexico is very problematic,” she said. She also noted that “Both Arizona and New Mexico have relatively large Native American population and when you look at the demographics, what is clear is the overdose mortality among Native Americans is double that of the general rest of the United States.”